Related Experiment Videos

Low level toxicity and antitumor activity of butyric mono- and polyester monosaccharide derivates in mice

P Pouillart1, G Ronco, I Cerutti

  • 1Laboratoire de Chimie Organique et Cinétique, UFR des Sciences, Université de Picardie, Amiens, France.

Insights

This study investigated butyric acid esters derived from monosaccharides for antitumor activity against Crocker Sarcoma. These compounds demonstrated low toxicity and improved antitumor effects when combined with immunotherapy.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Monosaccharide-derived butyric acid esters are novel compounds with potential therapeutic applications.
  • The Crocker 180 TG Sarcoma is a murine model used to evaluate antitumor agents.

Purpose of the Study:

  • To compare the antitumor activity of five n-butyric acid esters derived from monosaccharides.
  • To assess the acute toxicity and side effects of these esters.
  • To identify promising candidates for further in vivo and in vitro investigation.

Main Methods:

  • Antitumor activity was evaluated in the murine model of Crocker 180 TG Sarcoma.
  • Tumor incidence, mean survival time, and survival rate were measured.
  • Acute toxicity was assessed via intraperitoneal and oral routes in mice and rats.
  • Water-solubility and comparative antitumor activity were analyzed.

Main Results:

  • All tested butyric esters significantly affected tumor incidence, mean survival time, and survival rate.
  • Combined treatment with butyric esters, interferon (IFN), and Corynebacterium parvum enhanced antitumor protection.
  • Butyric esters exhibited low acute toxicity with no observable side effects or impact on growth in rats.
  • Two specific isomers, derived from monoacetone glucose, were identified as promising candidates.

Conclusions:

  • Monosaccharide-derived n-butyric acid esters show significant antitumor potential.
  • These compounds possess a favorable toxicity profile, making them suitable for further research.
  • Combination therapy with immunotherapy agents can potentiate antitumor effects.
  • Specific isomers warrant further investigation for their therapeutic mechanisms.

Related Concept Videos